BioSpace News Archive

Cidara Therapeutics, Inc., a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, reported financial results for the second quarter ended June 30, 2021 and provided an update on its corporate activities and product pipeline.

Dermata Therapeutics, Inc. announced the pricing of its initial public offering of 2,571,428 shares of its common stock and accompanying warrants to purchase up to 2,571,428 shares of common stock.

GC Pharma announced the approval of GreenGene F [Recombinant Human Coagulation Factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with haemophilia A in China by the National Medical Products Administration.

Immunity is a biological defense mechanism to avoid infection or disease. When the autoimmune system fails, biologic drugs play a vital role in defending against diseases or infections by boosting the immune system.

Urine collection devices are devices employed to collect urine from the urinary bladder either internally through inserting a catheter in the bladder to drain urine, or externally by using devices such as the Texas catheter.

The global market for transseptal access systems is predicted to witness a healthy growth in the next few years, thanks to the introduction of innovative technologies, including left trial appendage occlusion therapy, which has benefitted several patients.

Introduction of next-generation sequencing technology has increased demand for NGS-based RNA-seq across the globe.

Cancer is caused due to abnormal cell growth in an uncontrolled manner, with the potential to spread or invade other parts of the body. Initiation of cancer takes place when changes in the gene make a single cell or a few cells to grow and multiply.

Enteral syringes are used for administration of medications or feed to patients suffering from chronic illnesses, wherein the patients are unable to ingest food or medicines.

Electronic pills were first invented in 1972 by Dr. Eric Johannessen and Professor John Cooper.